These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2845768)

  • 1. Immediate and short-term cardiovascular effects of a new converting enzyme inhibitor (lisinopril) in essential hypertension.
    Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
    Am J Cardiol; 1988 Nov; 62(13):912-6. PubMed ID: 2845768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
    Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):214S-216S. PubMed ID: 2843195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertension.
    Oren S; Messerli FH; Grossman E; Garavaglia GE; Frohlich ED
    J Am Coll Cardiol; 1991 Apr; 17(5):1183-7. PubMed ID: 1826120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antihypertensive therapies by noninvasive techniques.
    Graettinger WF; Lipson JL; Klein RC; Cheung DG; Weber MA
    Chest; 1989 Jul; 96(1):74-9. PubMed ID: 2544352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lisinopril monotherapy on renal hemodynamics.
    Reams GP; Bauer JH
    Am J Kidney Dis; 1988 Jun; 11(6):499-507. PubMed ID: 2837083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic responses to converting enzyme inhibition in patients with renal disease.
    August P; Cody RJ; Sealey JE; Laragh JH
    Am J Hypertens; 1989 Aug; 2(8):599-603. PubMed ID: 2550029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ambulatory monitoring of arterial pressure in the treatment of mild-moderate arterial hypertension with lisinopril vs. enalapril].
    Motero Carrasco J
    Arch Inst Cardiol Mex; 1997; 67(1):29-37. PubMed ID: 9221708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and renal effects of enalapril and its effects on cardiac mass.
    Dunn FG; Oigman W; Ventura HO; Messerli FH; Kobrin I; Frohlich ED
    J Hypertens Suppl; 1984 Dec; 2(2):S57-61. PubMed ID: 6100878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lisinopril in the treatment of hypertension.
    Messerli FH; Kaesser UR
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():17-21. PubMed ID: 2550640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive and renal effects of lisinopril in older patients with hypertension.
    Laher MS; Donohoe JF; Kelly JG; Doyle GD
    Am J Med; 1988 Sep; 85(3B):38-43. PubMed ID: 2844086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses.
    Uretsky BF; Shaver JA; Liang CS; Amin D; Shah PK; Levine TB; Walinsky P; LeJemtel T; Linnemeier T; Rush JE
    Am Heart J; 1988 Aug; 116(2 Pt 1):480-8. PubMed ID: 2840815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 24-hour activity of lisinopril: clinical advantage in blood pressure control.
    Whelton A
    Cardiology; 1991; 79 Suppl 1():10-5. PubMed ID: 1655261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enalapril and lisinopril in the treatment of mild to moderate essential hypertension.
    Espinel CH; Williams JL; Coughlin SS
    Clin Ther; 1990; 12(2):181-90. PubMed ID: 2162258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of lisinopril after long-term administration in congestive heart failure.
    Stone CK; Uretsky BF; Linnemeier TJ; Shah PK; Amin DK; Snapinn SM; Rush JE; Langendörfer A; Liang CS
    Am J Cardiol; 1989 Mar; 63(9):567-70. PubMed ID: 2537566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive efficacy of lisinopril. Ambulatory blood pressure monitoring.
    Zachariah PK; Sheps SG; Schwartz GL; Schirger A; Ilstrup DM; Long CR; Carlson CA
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):274S-279S. PubMed ID: 2843199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preserved ventricular pump function after a marked reduction of left ventricular mass.
    Ketelhut R; Franz IW; Behr U; Toennesmann U; Messerli FH
    J Am Coll Cardiol; 1992 Oct; 20(4):864-8. PubMed ID: 1356116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension.
    Petersen JR; Drabaek H; Gleerup G; Mehlsen J; Petersen LJ; Winther K
    Angiology; 1996 Mar; 47(3):233-40. PubMed ID: 8638865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of isradipine and lisinopril on left ventricular structure and function in essential hypertension.
    Bielen EC; Fagard RH; Lijnen PJ; Tjandra-Maga TB; Verbesselt R; Amery AK
    Am J Cardiol; 1992 May; 69(14):1200-6. PubMed ID: 1315483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and chronic effects of lisinopril on renal and systemic hemodynamics in hypertension.
    Degaute JP; Leeman M; Reuse C; Carlier E; Schoutens A; Vandepapeliere P
    Cardiovasc Drugs Ther; 1992 Oct; 6(5):489-94. PubMed ID: 1333275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lisinopril dose-response relationship in essential hypertension.
    Gomez HJ; Cirillo VJ; Sromovsky JA; Otterbein ES; Shaw WC; Rush JE; Chrysant SG; Gradman AH; Leon AS; MacCarthy EP
    Br J Clin Pharmacol; 1989 Oct; 28(4):415-20. PubMed ID: 2556172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.